139 related articles for article (PubMed ID: 12935991)
21. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
22. [Prophylaxis and treatment of chronic graft versus host disease].
Huang K; Li Y; Huang SL; Fang JP; Zhou DH; Chen C
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):174-7. PubMed ID: 15833186
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients.
Baudard M; Vincent A; Moreau P; Kergueris MF; Harousseau JL; Milpied N
Bone Marrow Transplant; 2002 Sep; 30(5):287-95. PubMed ID: 12209350
[TBL] [Abstract][Full Text] [Related]
24. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.
Hardinger KL; Brennan DC; Lowell J; Schnitzler MA
Transpl Int; 2004 Nov; 17(10):609-16. PubMed ID: 15517170
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.
Ahmad HN; Thomas-Dewing RR; Hunt BJ
Eur J Haematol; 2007 May; 78(5):449-52. PubMed ID: 17331134
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
29. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
30. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy.
Grundmann-Kollmann M; Behrens S; Gruss C; Gottlöber P; Peter RU; Kerscher M
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):134-6. PubMed ID: 10607334
[TBL] [Abstract][Full Text] [Related]
31. [Mycophenolate mofetil].
Abramowicz D; Broeders N; Wissing M; Sternon J
Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.
Kiehl MG; Schäfer-Eckart K; Kröger M; Bornhäuser M; Basara N; Blau IW; Kienast J; Fauser AA; Ehninger G; Armstrong VW; Shipkova M
Transplant Proc; 2002 Nov; 34(7):2922-4. PubMed ID: 12431658
[No Abstract] [Full Text] [Related]
33. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
[TBL] [Abstract][Full Text] [Related]
34. Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Pérez-Simón JA; Martino R; Caballero D; Valcarcel D; Rebollo N; de la Cámara R; de Oteiza JP; Heras I; Calvo MV; Sierra J; San Miguel JF;
Biol Blood Marrow Transplant; 2008 Jun; 14(6):664-71. PubMed ID: 18489992
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil and skin diseases.
Hartmann M; Enk A
Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation.
Hambach L; Stadler M; Dammann E; Ganser A; Hertenstein B
Bone Marrow Transplant; 2002 Jun; 29(11):903-6. PubMed ID: 12080355
[TBL] [Abstract][Full Text] [Related]
37. Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease.
Kennedy GA; Butler J; Western R; Morton J; Durrant S; Hill GR
Bone Marrow Transplant; 2006 Jun; 37(12):1143-7. PubMed ID: 16699531
[TBL] [Abstract][Full Text] [Related]
38. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
40. Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.
Jackson JM; Fowler JF; Callen JP; Lorenz DJ
J Drugs Dermatol; 2010 Apr; 9(4):356-62. PubMed ID: 20514793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
